The California agency hosted a half-day panel discussion about why it’s different working with a West Coast firm.
How does the human journey in healthcare differ from the patient journey? Craig Haines, chief revenue officer of Verywell, explains the broader implications of that shift for brands and marketers.
As targeted therapies become more prevalent, how can healthcare marketers support providers and other extenders to ensure readiness to treat and prescribe these new methods?
Execs from Medisafe, Phreesia and Heartbeat share examples of POC programs that drove better short- and long-term adherence rates than seen before.
At W2O’s second Marketing Science Summit, pioneers in the fields of market research, social analytics and digital marketing shared the latest trends in marketing science, with a focus on the healthcare and tech industries.
The TrialCard acquisition of San Francisco-based Mango Health is a win-win for patients and pharma.
Miriam Paramore, president and chief strategy officer of OptimizeRx, underscores the value that personalized messaging brings to the patient and to the healthcare provider.
Best practices manufacturers can leverage to ensure accurate and timely data is available at launch and beyond.
Marketers from Dudnyk, 81qd, Guidemark Health and The Bloc share their expertise.
Spectrum Science’s Jonathan Wilson, CEO, Michelle Gross, president, and Justin Rubin, chief creative officer, reflect on how the agency’s strategy-first approach is evolving, going beyond the ‘science quo” to deliver media-neutral “atomic creative” for client campaigns.